Invenra Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 57

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Invenra General Information

Description

Developer of a drug research platform designed to help discover and optimize human multi-specific antibodies. The company's platform is used to discover and develop new biologic drugs for cancer, Alzheimer's disease, and diabetes, enabling healthcare institutes to optimize bispecific formatting, binding affinities, candidate pairings, and linkers in biologically relevant assays.

Contact Information

Website
www.invenra.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5510 Element Way
  • Suite 400
  • Madison, WI 53719
  • United States
+1 (608)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 5510 Element Way
  • Suite 400
  • Madison, WI 53719
  • United States
+1 (608)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Invenra Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private Completed Generating Revenue
7. Debt - PPP 10-Apr-2020 Completed Generating Revenue
6. Later Stage VC (Series B) 16-Oct-2018 Completed Generating Revenue
5. Later Stage VC (Series A) 03-Oct-2017 Completed Generating Revenue
4. Early Stage VC 01-Sep-2015 Completed Pre-Clinical Trials
3. Early Stage VC 01-Jan-2015 Completed Pre-Clinical Trials
2. Early Stage VC 19-Feb-2013 $3M $4.2M Completed Pre-Clinical Trials
1. Early Stage VC 18-Jan-2012 $1.2M $1.2M Completed Pre-Clinical Trials
To view Invenra’s complete valuation and funding history, request access »

Invenra Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Invenra’s complete cap table history, request access »

Invenra Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug research platform designed to help discover and optimize human multi-specific antibodies. The compan
Drug Discovery
Madison, WI
57 As of 2026

San Diego, CA
 

Saint Louis, MO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Invenra Competitors (85)

One of Invenra’s 85 competitors is Vividion Therapeutics, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vividion Therapeutics Formerly VC-backed San Diego, CA
Euclises Venture Capital-Backed Saint Louis, MO
BioTheryx Venture Capital-Backed San Diego, CA
Actym Therapeutics Venture Capital-Backed Berkeley, CA
Cantex Pharmaceuticals Formerly VC-backed Weston, FL
You’re viewing 5 of 85 competitors. Get the full list »

Invenra Patents

Invenra Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026152157-A2 Domain pair Pending 13-Jan-2025
WO-2026152157-A3 Domain pair Pending 13-Jan-2025
WO-2026152160-A2 Domain pair for antibody constructs Pending 13-Jan-2025
EP-4824105-A1 Multispecific binding agents that target ctla4 and/or cd25 and uses thereof Pending 14-Dec-2023
WO-2025129132-A1 Multispecific binding agents that target ctla4 and/or cd25 and uses thereof Inactive 14-Dec-2023 C07K16/2818
To view Invenra’s complete patent history, request access »

Invenra Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Invenra Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Clarevia Ventures Venture Capital Minority
Rose Ventures Venture Capital Minority
Wisconsin Investment Partners Angel Group Minority
To view Invenra’s complete investors history, request access »

Invenra Investments (1)

Invenra’s most recent deal was a Joint Venture with WIN Therapeutics.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
WIN Therapeutics Joint Venture Drug Discovery
To view Invenra’s complete investments history, request access »

Invenra FAQs

  • When was Invenra founded?

    Invenra was founded in 2011.

  • Where is Invenra headquartered?

    Invenra is headquartered in Madison, WI.

  • What is the size of Invenra?

    Invenra has 57 total employees.

  • What industry is Invenra in?

    Invenra’s primary industry is Drug Discovery.

  • Is Invenra a private or public company?

    Invenra is a Private company.

  • What is Invenra’s current revenue?

    The current revenue for Invenra is .

  • How much funding has Invenra raised over time?

    Invenra has raised $21.3M.

  • Who are Invenra’s investors?

    Clarevia Ventures, Rose Ventures, and Wisconsin Investment Partners have invested in Invenra.

  • Who are Invenra’s competitors?

    Vividion Therapeutics, Euclises, BioTheryx, Actym Therapeutics, and Cantex Pharmaceuticals are some of the 85 competitors of Invenra.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process